Study to Evaluate Safety, Immunogenicity and Dose Response of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years.
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2012
At a glance
- Drugs Measles virus vaccine live; MVA-mBN85B
- Indications Measles
- Focus Adverse reactions; Pharmacodynamics
- 26 Jul 2012 Actual end date (1 Aug 2010) added as reported by ClinicalTrials.gov.
- 01 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.